PAR 3.77% 25.5¢ paradigm biopharmaceuticals limited..

research reports and media, page-4161

  1. 4,252 Posts.
    lightbulb Created with Sketch. 6737
    I more meant TGA...

    But yeah, under FT designation that should help with FDA to bump us up on the priority list, at least to not take overly long to get back and the to's and fro's.


 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.